The Federal Drug Enforcement Agency (DEA) requested on Thursday the internal control body of the United States Department of Justice (DOJ, in English). to investigate whistleblower allegations that DEA agents allowed hundreds of thousands of fentanyl pills to hit the streets of New Mexico.
The request came just days after an Associated Press investigation revealed that between 2023 and 2025, agents repeatedly monitored — but did not seize — significant shipments of the synthetic opioid in preparation for larger criminal cases.
In a letter sent Thursday to the DOJ inspector general, DEA Director Terry Cole wrote that an internal investigation was necessary because “the allegations have sparked widespread public interest and raised questions about the DEA’s operational decisions, its oversight of its activities, and its response to concerns raised.”
Cole wrote in a public statement that his request “should not be construed as a lack of confidence in the professionalism or integrity of DEA personnel, nor in the investigative decisions made in connection with this matter.”
“If aspects that can be improved are detected, the DEA will put them into practice,” he added. “Strong institutions are maintained—and not weakened—by objective oversight and a willingness to continually evaluate and improve.”
Current and former DEA agents told the AP that the investigative strategy — known as “passing” counterfeit painkillers — amounted to a risky gamble with public safety in a state ravaged by the fentanyl epidemic and may have violated DOJ rules intended to protect communities from a drug that White House classified last year as a “weapon of mass destruction.”
The AP investigation cited three active and retired agents, as well as official documents, including an internal report about a 2023 delivery of 74,000 pills that the DEA oversaw at an Albuquerque mobile home park. One of those agents, David Howell, was the first to raise serious concerns about this strategy in a 2023 whistleblower complaint. He continued to raise his objections internally and spoke at length to the AP about what he described as a strategy that “poisoned our community to get cases.”
In a previous statement to the AP agency, a DEA spokesperson stated that “public claims suggesting that the DEA knowingly allowed fentanyl to reach communities are false and fundamentally misrepresent the facts.”
The DEA’s request for the watchdog to conduct an investigation came just one day after New Mexico Gov. Michelle Lujan Grisham asked the state’s attorney general to examine whether the agency’s actions violated New Mexico law, presenting an extraordinary challenge for a federal law enforcement agency at a time when fentanyl remains one of the nation’s deadliest public health threats.
“There are no words to describe how reckless and dangerous these decisions were,” Lujan Grisham said in a statement. “Let’s be clear: the DEA knew there would be fatalities if these pills reached communities in New Mexico, and yet the agency allowed that to happen.”
The Ministry of Justice has stated in a statement that it welcomes the collaboration with New Mexico leaders to ensure the security of the state.
“Protecting citizens requires more than addressing individual transactions as they occur,” the statement states. “It requires identifying the sources of supply, the people directing criminal activity and the organizations responsible for introducing dangerous drugs into our communities.”
For its part, Democratic congressmen from New Mexico sent a letter to Cole requesting information about DEA tactics in the state.
“New Mexicans are paying the price for a fentanyl epidemic that is destroying families and they deserve answers,” said US Congresswoman Melanie Stansbury in a statement. “At a time when overdose deaths continue to devastate our state and our communities, the DEA should focus on stopping these drugs before they reach our streets, period.”
